Eli Lilly, meanwhile, also revealed that it had paused work on its Gateway Labs biotech incubator – part of a £279 million ...

The UK government is reported to be trying to restart talks over drug pricing and rebates after MSD's shock decision to scrap ...

The Series 11 Apple Watch can spot signs of chronic high blood pressure and warn users that they may have hypertension, ...

The case dates back to 2014, when Ronald Streck, a former executive at a network of regional drug wholesalers, failed a ...

The PMi Awards 2025 – formerly known as the PM Society Digital Awards – celebrated its inaugural edition under its new name ...

In a Securities & Exchange Commission (SEC) filing (PDF), AbbVie said it had reached an agreement with "all generic ...

Generics company Zentiva is reported to be poised for a sale by current owner Advent International to US investment group ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brian Coane, health partner at creative agency Leith, ...

NRG's R&D pipeline is focused on brain-penetrant, small-molecule inhibitors of the mitochondrial permeability transition pore ...

There has been widespread condemnation of the comments, as well as the decision by Reform UK and its leader, Nigel Farage, to ...

New York-based LB is hoping to raise up to $263 million by offering 16.7 million shares at a price of between $14 and $16, ...

The success of pharmaceutical companies in developing drugs for treating and curing medical conditions is largely dependent ...